1. Home
  2. RFL vs VNRX Comparison

RFL vs VNRX Comparison

Compare RFL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.30

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.24

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RFL
VNRX
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RFL
VNRX
Price
$1.30
$0.24
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.17
AVG Volume (30 Days)
143.0K
2.8M
Earning Date
12-11-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,029,000.00
$1,472,007.00
Revenue This Year
N/A
$55.33
Revenue Next Year
N/A
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
47.63
14.48
52 Week Low
$1.17
$0.27
52 Week High
$3.19
$0.94

Technical Indicators

Market Signals
Indicator
RFL
VNRX
Relative Strength Index (RSI) 43.01 27.78
Support Level $1.21 $0.28
Resistance Level $1.60 $0.31
Average True Range (ATR) 0.11 0.03
MACD 0.00 0.00
Stochastic Oscillator 13.95 8.26

Price Performance

Historical Comparison
RFL
VNRX

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: